Search
Search Results
-
Prostate Cancer Advancements in the Pathogenesis, Diagnosis and Personalized Therapy
This book provides an in-depth exploration of the biology of prostate cancer, from its cellular origins to its clinical manifestations and...
-
Prostate Cancer
Prostate cancer is a highly prevalent cancer in older men. Its clinical course is extremely variable. Detection of prostate cancer has been improved...
-
Perspectives of Immunotherapy in Prostate Cancer
Prostate cancer, a major twenty-first-century health concern, often remains asymptomatic in its early stages but can lead to urinary, pelvic, and...
-
Prostate Cancer and Radiotherapy
Prostate cancer represents the most common malignancy in males [1, 2] and its incidence increased in the last decades due to the introduction of the...
-
Hormone Therapy for Advanced Prostate Cancer
The identification of probable sources of androgen and strategies for lowering their levels are essential to the characterization of advanced PC. The...
-
Genetic Susceptibility to Prostate Cancer
Prostate cancer (PCa) is the second most diagnosed cancer type globally and is one of the leading causes of death in men. Genetic susceptibility...
-
Surgical Treatment of Prostate Cancer
Radical retropubic prostatectomy (RP) is a method of treatment of a localized prostate cancer (PC), while in the treatment of locally advanced PC, it...
-
Biological Markers of Therapeutic Response in Prostate Cancer
The remarkable variability in clinical behaviour of prostate cancer necessitates an individualized approach to therapy. The reliance on conventional...
-
Basic Insights into Tumor Microenvironment in Prostate Cancer
Prostate cancer, a prominent malignancy impacting men worldwide, is characterized by a dynamic and intricate interplay between cancer cells and their...
-
Prostate Cancer: Epidemiology, Etiology, Pathogenesis, and Risk Factors
Prostate cancer is today the most common cancer in men in developed countries. The very high incidence of prostate cancer in the developed world...
-
Metabolic Reprogramming As a Prostate Cancer Hallmark
Arising from a disruption of regular biological circuits and control mechanisms, cancer exhibits a remarkable inter- and intra-type heterogeneity, an...
-
Multivitamin use after diagnosis and prostate cancer survival among men with nonmetastatic prostate cancer
BackgroundMultivitamin use is common among cancer patients. Whether post-diagnostic multivitamin supplementation is beneficial for prostate cancer...
-
Current Pathophysiology, Treatment, and Future Perspective for Prostate Cancer
Prostate Cancer (PCa) is one of the most common types of cancer in Western countries Asia due to uncontrolled cell proliferation of the prostate...
-
Treatment of Castration-Resistant Prostate Cancer
Castration-resistant prostate cancer (CRPC) is a major therapeutic problem. Resistance to androgen deprivation therapy occurs in many patients after...
-
Stereotactic Radiotherapy in the Treatment of Prostate Cancer
Stereotactic body radiotherapy (SBRT) is a technologically sophisticated form of radiotherapy and well-established treatment option for patients with...
-
Pharmacogenomics and Precision Therapy in Prostate Cancer: Challenges and Perspectives
Advancements in genoty** and sequencing technologies have driven the rapid progress in human genetics research over the last 20 years. Particularly...
-
Recent Advances of Iron Oxide Nanoparticles-Based Nanomedicine for Prostate Cancer (Review)
Prostate cancer (PC) is one of the commonly diagnosed cancers among men in the world. Clinical outcomes are excellent for patients with localized...
-
Generation of Radioresistant Prostate Cancer Cells
The development of in vitro isogenic models of radioresistance through exposure to fractionated radiation is an increasingly used approach to...
-
Circulating Tumor Cells in Men Treated for Prostate Cancer
Despite the advancements in prostate cancer treatments, a significant proportion of men with higher risk features (approximately 25-50%) ultimately...
-
Prostate Cancer Organoids for Tumor Modeling and Drug Screening
Prostate cancer (PCa) is the second most common malignancy and the fifth leading cause of cancer death in men worldwide. Despite its prevalence, the...